seen from United States
seen from Spain
seen from United States
seen from Costa Rica
seen from United States
seen from United States
seen from United States
seen from Spain
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from China
seen from United States
seen from Brazil
Novo to market ‘connected’ insulin pens next year Building upon its existing work with IBM Watson Health and Glooko, Novo Nordisk aims to integrate insulin dosing data from connected pen devices with its partners’ open ecosystems and diabetes management solutions, such as data from continuous glucose monitoring (CGM) systems and blood glucose meters (BGM).
